Stock KMDA KAMADA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kamada Ltd.

Equities

KMDA

IL0010941198

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:54:03 02/05/2024 pm IST 		5-day change 1st Jan Change
2,049 ILa +3.22% Intraday chart for Kamada Ltd. +3.17% -7.99%
06/03 Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024
06/03 Kamada Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
AQ
Transcript : Kamada Ltd., Q4 2023 Earnings Call, Mar 06, 2024
Kamada: Q4 Earnings Snapshot
AQ
Kamada : Reports Fiscal Year and Fourth Quarter 2023 Financial Results, CEO letter and presentation
PU
Kamada Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Kamada : 20F 2023 Annual Report
PU
Kamada Issues 2024 CEO Letter to Shareholders
AQ
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
AQ
Kamada Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kamada Ltd. Provides Revenue Guidance for the Year 2024
CI
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024
AQ
Kamada : Results of Annual General Meeting of Shareholders held on December 28, 2023
PU
Kamada : Other Information - Form 6-K
PU
PRISM MarketView Biotech Index Top Mover Spotlight: Kamada Ltd.
AQ
Kamada, Kedrion Extend US Distribution Deal for Kedrab
MT
Kamada Amends, Extends Kedrab Distribution Deal With Kedrion Biopharma; Shares Surge 20% Pre-Bell
MT
Transcript : Kamada Ltd. - Special Call
Top Premarket Gainers
MT
Kamada Ltd. Announces the Execution of A Binding Memorandum of Understanding with Kedrion
CI
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KMDA Stock
  4. News Kamada Ltd.